Prognostic role of body composition parameters in gastric/gastroesophageal junction cancer patients from the EXPAND trial.

Ulrich T HackerDirk HasencleverNicolas LinderGertraud StockerHyun-Cheol ChungYoon-Koo KangMarkus MoehlerHarald BusseFlorian Lordick

Published in: Journal of cachexia, sarcopenia and muscle (2019)

Among body composition parameters, only MA has robust prognostic impact for OS. Data suggest that treatment approaches targeting muscle quality are unlikely to prolong OS noticeably on their own in advanced gastric cancer patients, indicating that multimodal approaches should be pursued in the future.

Keyphrases

body composition
resistance training
bone mineral density
clinical trial
skeletal muscle
study protocol
phase ii
phase iii
current status
pain management
big data
quality improvement
drug delivery
machine learning
deep learning
chronic pain
placebo controlled